| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.91B | 61.60B | 62.77B | 61.04B | 61.58B | 63.12B |
| Gross Profit | 15.92B | 15.96B | 15.34B | 14.42B | 14.57B | 16.03B |
| EBITDA | 3.84B | 4.37B | 3.40B | 2.24B | 2.32B | 3.63B |
| Net Income | 2.43B | 1.93B | 1.99B | 877.00M | -665.00M | 1.02B |
Balance Sheet | ||||||
| Total Assets | 55.22B | 54.08B | 56.58B | 57.97B | 57.70B | 58.23B |
| Cash, Cash Equivalents and Short-Term Investments | 7.75B | 6.80B | 7.74B | 7.21B | 7.87B | 8.10B |
| Total Debt | 12.33B | 10.61B | 13.72B | 15.03B | 15.76B | 13.63B |
| Total Liabilities | 25.77B | 23.13B | 27.20B | 29.84B | 30.85B | 29.72B |
| Stockholders Equity | 28.80B | 30.79B | 28.72B | 27.44B | 26.20B | 26.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.67B | 1.95B | -341.00M | -1.51B | 1.04B |
| Operating Cash Flow | 0.00 | 3.24B | 2.79B | 1.33B | -87.00M | 2.23B |
| Investing Cash Flow | 0.00 | 257.00M | -396.00M | -1.13B | -1.33B | -283.00M |
| Financing Cash Flow | 0.00 | -3.83B | -1.97B | -1.42B | 1.07B | -299.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥3.66B | 19.86 | ― | 1.93% | 2.69% | 8.14% | |
67 Neutral | ¥14.50B | 3.79 | ― | 3.79% | -1.86% | -2.61% | |
64 Neutral | ¥38.77B | 11.25 | ― | 3.71% | -1.77% | 22.86% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥6.75B | 11.68 | ― | 2.94% | 4.24% | 193.06% | |
55 Neutral | ¥3.25B | 7.47 | ― | 3.69% | -3.80% | -29.59% | |
54 Neutral | ¥5.80B | 15.83 | ― | 2.72% | -4.22% | 400.40% |